DE602006021178D1 - Cspcna-isoform-modifikationen und anwendungen davon - Google Patents

Cspcna-isoform-modifikationen und anwendungen davon

Info

Publication number
DE602006021178D1
DE602006021178D1 DE602006021178T DE602006021178T DE602006021178D1 DE 602006021178 D1 DE602006021178 D1 DE 602006021178D1 DE 602006021178 T DE602006021178 T DE 602006021178T DE 602006021178 T DE602006021178 T DE 602006021178T DE 602006021178 D1 DE602006021178 D1 DE 602006021178D1
Authority
DE
Germany
Prior art keywords
applications
cspcna isoform
modifications
cspcna
isoform modifications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006021178T
Other languages
English (en)
Inventor
Derek J Hoelz
Robert J Hickey
Linda H Malkas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indiana University Research and Technology Corp
Original Assignee
Indiana University Research and Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indiana University Research and Technology Corp filed Critical Indiana University Research and Technology Corp
Publication of DE602006021178D1 publication Critical patent/DE602006021178D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Insulating Materials (AREA)
DE602006021178T 2005-06-27 2006-06-26 Cspcna-isoform-modifikationen und anwendungen davon Active DE602006021178D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69415905P 2005-06-27 2005-06-27
PCT/US2006/024774 WO2007002574A2 (en) 2005-06-27 2006-06-26 Cspcna isoform modifications and uses thereof

Publications (1)

Publication Number Publication Date
DE602006021178D1 true DE602006021178D1 (de) 2011-05-19

Family

ID=37116243

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006021178T Active DE602006021178D1 (de) 2005-06-27 2006-06-26 Cspcna-isoform-modifikationen und anwendungen davon

Country Status (12)

Country Link
US (2) US7932023B2 (de)
EP (1) EP1899373B1 (de)
JP (1) JP5090344B2 (de)
CN (1) CN101258161A (de)
AT (1) ATE504598T1 (de)
AU (1) AU2006261856B2 (de)
BR (1) BRPI0611703A2 (de)
CA (1) CA2612695A1 (de)
DE (1) DE602006021178D1 (de)
EA (1) EA013109B1 (de)
HK (1) HK1112928A1 (de)
WO (1) WO2007002574A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007217037A1 (en) * 2006-02-17 2007-08-30 Indiana University Research And Technology Corporation Peptide based inhibition of caPCNA protein-protein interactions in cancer
CA3156093A1 (en) * 2008-07-24 2010-01-28 Indiana University Research And Technology Corporation Cancer peptide therapeutics
WO2011044372A1 (en) * 2009-10-09 2011-04-14 Indiana University Research And Technology Corporation Pcna methyltransferase
US8455200B2 (en) 2009-10-15 2013-06-04 Traxxsson, Llc Measurement of PKA for cancer detection
CN103619331A (zh) * 2011-03-23 2014-03-05 印第安纳大学研究及科技公司 抗癌治疗剂
US10420840B2 (en) * 2015-04-10 2019-09-24 Rll, Llc Anticancer therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294471B2 (en) * 2002-02-27 2007-11-13 Cskeys, Llc Method for purifying cancer-specific proliferating cell nuclear antigen

Also Published As

Publication number Publication date
EA200800144A1 (ru) 2008-06-30
EP1899373A2 (de) 2008-03-19
WO2007002574A3 (en) 2007-05-03
CN101258161A (zh) 2008-09-03
WO2007002574A2 (en) 2007-01-04
US20090061432A1 (en) 2009-03-05
EA013109B1 (ru) 2010-02-26
BRPI0611703A2 (pt) 2011-12-20
JP5090344B2 (ja) 2012-12-05
AU2006261856A1 (en) 2007-01-04
EP1899373B1 (de) 2011-04-06
AU2006261856B2 (en) 2012-07-05
HK1112928A1 (en) 2008-09-19
JP2008547034A (ja) 2008-12-25
ATE504598T1 (de) 2011-04-15
CA2612695A1 (en) 2007-01-04
US20110195510A1 (en) 2011-08-11
US7932023B2 (en) 2011-04-26

Similar Documents

Publication Publication Date Title
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
BR112012008385A2 (pt) inibidores de p13 cinase e uso dos mesmos.
BR112012028467A2 (pt) composições e métodos que compreendem variantes de subtilisina
PA8713501A1 (es) INHIBIDORES DE 11-BETA HIDROXIESTEROIDE DEHIDROGENASA - 11ßHSD1
ATE554105T1 (de) Veränderte antikörper
ATE471324T1 (de) Triazolophthalazine
ATE498134T1 (de) Nachweis von staphylococcus
PA8667201A1 (es) Nuevos compuestos farmaceuticos
DK2327792T3 (da) Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme
ATE507721T2 (de) Milbenzusammensetzung
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
DE602006015929D1 (de) Doxorubicin-immuntest
CY1113916T1 (el) Παραγωγα ετεροαρυλο πυρρολιδινυλο και πιπεριδινυλο κετονης
CR20140128A (es) Inhibidores de la enzima activadora de nedd 8
MX2011010012A (es) NUEVOS ANTICUERPOS ANTI-A5ß1 Y SUS USOS.
ATE504598T1 (de) Cspcna-isoform-modifikationen und anwendungen davon
AR059851A1 (es) Anticuerpos de la egfl7 y metodos de uso
FR2897063B1 (fr) Polypeptides reconnus par des anticorps anti-trichinella, et leurs applications.
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
MX341064B (es) Variantes de la familia il-1.
CR20120314A (es) NUEVOS DERIVADOS DE (HETEROCICLO-PIPERIDINA CONDENSADA)-(PIPERAZINIL)-1-ALCANONA O DE (HETEROCICLO-PIRROLIDINA CONDENSADA)-(PIPERAZINIL)-1-ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75
TR201109686T2 (tr) Olmesartan'ın Farmasötik Bileşimleri.
EA200701626A1 (ru) Новые 6-пиридилфенантридины